Inorganic and Nano-Metal Chemistry is a premier journal published by Taylor & Francis Inc, focusing on innovative research and advancements in the fields of inorganic chemistry and nano-metal applications. With an increasing impact in the academic community, this journal has established itself within the Q3 category of both Inorganic Chemistry and Physical and Theoretical Chemistry as of 2023, reflecting its global recognition and influence. The journal is accessible as an Open Access publication, ensuring that research findings are freely available to a broad audience, promoting transparency and collaboration in scientific exploration. Based in the United Kingdom, Inorganic and Nano-Metal Chemistry aims to disseminate high-quality peer-reviewed articles that not only highlight fundamental studies but also push the boundaries of technological applications in areas such as catalysis, materials science, and nanotechnology. Researchers, professionals, and students will find this journal an invaluable resource for the latest developments and interdisciplinary insights in the ever-evolving landscape of inorganic and nano-metal chemistry.

NANO is an esteemed academic journal published by World Scientific Publishing Co. Pte Ltd, focusing on the frontier of nanoscience and nanotechnology. With ISSN 1793-2920 and E-ISSN 1793-7094, this journal has been a pivotal platform for disseminating innovative research from 2008 to 2024. Located in Singapore, NANO has established itself within the academic community, currently holding notable rankings in the Q3 Category for both Condensed Matter Physics and Materials Science, as well as a Q4 Category status in Nanoscience and Nanotechnology. Though it operates under a non-open access model, its contributions are invaluable for researchers, professionals, and students seeking to stay abreast of the latest advancements and interdisciplinary approaches within the nanoscale domain. By providing in-depth articles, reviews, and insights, NANO plays a significant role in advancing our understanding of materials at the nanoscale, thereby fostering innovation and collaboration across related fields.

Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.

PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION is a distinguished journal dedicated to advancing the knowledge within the fields of Chemistry, Condensed Matter Physics, and Materials Science. Published by WILEY-V C H VERLAG GMBH in Germany, this journal has established a solid reputation since its inception in 1984, showcasing research aimed at understanding the intricate properties and behaviors of particulate systems. With an impressive Q2 ranking in its respective categories and Scopus ranks indicating a robust standing in the global research community, it serves as an essential resource for researchers, professionals, and students. Although it does not currently offer Open Access options, its comprehensive articles and reviews provide valuable insights that contribute significantly to the ongoing discourse in these scientific domains. As it prepares to celebrate four decades of publication, PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION continues to provide a vital platform for emerging knowledge, fostering innovation and collaboration among scientists dedicated to the study of particle systems.

Nanomedicine Journal, published by Mashhad University of Medical Sciences, serves as a vital platform for research and developments in the dynamic field of nanotechnology applied to medicine. With an ISSN of 2322-3049 and an E-ISSN of 2322-5904, this Open Access journal, operational since 2013, makes cutting-edge research freely accessible to encourage collaborative efforts in this rapidly evolving domain. The journal navigates various areas, including bioengineering, biomedical engineering, materials science, and pharmacology, holding prestigious rankings in categories relevant to these fields. The 2023 Scopus Rankings reveal its significant standing within the scientific community, particularly with a 76th percentile in general medicine. By bridging the gap between laboratory technologies and clinical applications, the Nanomedicine Journal aims to empower researchers, professionals, and students alike to contribute to the innovative landscape of nanomedicine. With a convergence period extending from 2019 to 2024 and an established reputation, this journal is essential for those pursuing advancements in therapeutic solutions and diagnostics through nanotechnology.

BIOMATERIALS, published by Elsevier Science Ltd, is a premier academic journal dedicated to the interdisciplinary field of biomaterials research. With an impressive impact factor, it ranks in the Q1 quartile across multiple categories including Bioengineering, Biomaterials, and Biophysics, showcasing its significance in advancing scientific knowledge. Established in 1980 and set to converge its discussions through 2025, this journal provides a critical platform for researchers and professionals to disseminate their findings on the development, application, and performance of biomaterials. The journal covers a wide range of topics, from the mechanics of materials to nanotechnology, and is highly regarded with top Scopus rankings in essential categories, including an exceptional position within the 99th percentile for Biophysics. Although not an open access journal, BIOMATERIALS remains vital for students and established researchers alike, ensuring accessibility to groundbreaking research in the field. Engage with cutting-edge studies that pave the way for innovative applications in medicine, engineering, and beyond.

ADVANCED DRUG DELIVERY REVIEWS, published by ELSEVIER, is a leading journal in the field of pharmaceutical sciences, particularly acclaimed for its contributions to the disciplines of pharmacology, toxicology, and pharmaceutics. With an impressive 2023 Scopus rank of #1 out of 183 in its category, this journal is situated in the Q1 quartile, reflecting its high impact and the relevance of its published research. Since its inception in 1987, it has continually focused on the latest advancements in drug delivery systems, making it an indispensable resource for researchers, professionals, and students interested in the innovative developments that shape the pharmaceutical landscape. The journal aims to publish comprehensive and authoritative reviews that foster a deeper understanding of drug delivery mechanisms, technologies, and their clinical applications. Although it operates under a subscription model, the value it provides through rigorous peer-reviewed content ensures it remains an essential tool for anyone seeking to enhance their knowledge in this rapidly evolving field.

MOLECULES, published by MDPI, stands as a prominent open-access journal dedicated to the field of chemistry, with an exceptional reputation in various sub-disciplines. Since its inception in 1997, this journal has committed itself to the dissemination of innovative research, spanning topics in Analytical Chemistry, Organic Chemistry, Pharmaceutical Science, and Drug Discovery. With impressive rankings across Scopus categories—including a coveted Q1 designation in both Analytical Chemistry and Pharmaceutical Science—MOLECULES is recognized as a vital resource for researchers, professionals, and students aiming to stay at the forefront of scientific development. The journal’s data reflect its wide-ranging influence, holding high percentiles in multiple chemistry categories, thereby ensuring that its articles reach a significant audience. As an open-access journal, it provides unparalleled access to its content, available freely and globally, which promotes further advancement and collaboration within the scientific community. Its ongoing commitment to high-quality research from 1996 to 2024 reinforces its status as a leader in the academic publishing landscape.

Nanomaterials and Nanotechnology is a premier journal published by HINDAWI LTD, dedicated to advancing knowledge in the rapidly evolving fields of nanomaterials and nanoscale applications. Established as an Open Access platform since 2011, the journal aims to disseminate high-quality research that provides insights into nanotechnology's manifold aspects, including biotechnology, ceramics and composites, as well as electrical and electronic engineering. With a compelling impact factor reflected in its robust Scopus rankings—placing it in the 80th percentile in Engineering and the 72nd percentile in Biotechnology—it stands as a key resource for researchers, professionals, and students seeking to stay at the forefront of innovation in materials science. The journal occupies a distinguished position in the academic community, featuring studies that explore the synthesis, characterization, and application of nanomaterials, thereby contributing significantly to scientific discourse and technological advancement in this critical area.

Nanobiotechnology Reports, an impactful journal published by PLEIADES PUBLISHING INC, serves as a prominent platform for disseminating cutting-edge research at the intersection of nanotechnology and biotechnology. With its ISSN 2635-1676 and E-ISSN 2635-1684, this open-access journal is committed to providing researchers, professionals, and students with accessible knowledge and innovations that drive advancements in this rapidly evolving field. Operating out of the United States, Nanobiotechnology Reports has established itself in various engineering and science categories, including Bioengineering and Biomedical Engineering, currently holding a Q4 quartile ranking in 2023. Although it is in the early stages of its publication journey since its convergence in 2021, the journal aims to foster collaboration and knowledge-sharing within the scientific community, addressing the complexities of nanomaterials and their applications in biological systems. Researchers and practitioners in nanobiotechnology are encouraged to contribute to this expanding body of knowledge, facilitating the development of innovative solutions that impact various sectors, from healthcare to electronics.